Skip to content

Clinical research for dissipating phlegm-turbid for coronary heart disease

Clinical research for Chinese herb for coronary heart disease

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019814
Enrollment
Unknown
Registered
2018-11-30
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Group 1:Chinese herb I
Group 2:Chinese herb II
Group 3:Standard treatment of westertn medicine

Sponsors

Wuxi Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) coronary angiography or coronary CTA confirmed that at least one major coronary artery stenosis was greater than 50%; (2) Patients between 18 and 75 years old; (3) signing the informed consent; (4) TCM syndrome are diagnosed as phlegm-turbid syndrome.

Exclusion criteria

Exclusion criteria: (1) infection, fever, trauma, burns, surgical history and inflammation within nearly one month; (2) active tuberculosis; (3) patients with active rheumatic immune diseases; (4) patients with severe liver, kidney, hematopoietic, nervous system diseases, mental diseases and malignant tumors; (5) the patient refuses to sign the informed consent form, or the compliance is estimated to be poor, and the possibility of follow-up is poor; (6) women who are pregnant or breast-feeding; (7) participate involved in other researchers.

Design outcomes

Primary

MeasureTime frame
Major adverse cardiovascular events;

Secondary

MeasureTime frame
Angina score;TCM symptom score;WHO Quality of Life-BREF;blood biochemical indexes;index of security;electrocardiograph;

Countries

China

Contacts

Public ContactTan Xiaodong

Nanjing University of Chinese Wuxi Branch

txd1985123@163.com+86 0510-88859999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026